Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Equity Ratio (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Equity Ratio for 13 consecutive years, with 0.45 as the latest value for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 5.86% to 0.45 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.45, a 5.86% decrease, with the full-year FY2025 number at 0.45, down 5.86% from a year prior.
  • Equity Ratio was 0.45 for Q4 2025 at Ekso Bionics Holdings, roughly flat from 0.45 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.78 in Q2 2022 to a low of 0.44 in Q4 2023.
  • A 5-year average of 0.58 and a median of 0.52 in 2023 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: surged 251.65% in 2021, then plummeted 33.09% in 2023.
  • Ekso Bionics Holdings' Equity Ratio stood at 0.76 in 2021, then decreased by 17.83% to 0.62 in 2022, then decreased by 29.92% to 0.44 in 2023, then rose by 9.37% to 0.48 in 2024, then dropped by 5.86% to 0.45 in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Equity Ratio are 0.45 (Q4 2025), 0.45 (Q3 2025), and 0.47 (Q2 2025).